Department of Dermatology and Venereology, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Indian J Dermatol Venereol Leprol. 2019 Jul-Aug;85(4):388-392. doi: 10.4103/ijdvl.IJDVL_319_18.
Dermatophytosis is a major public health problem in our country. Although resistance to conventional oral and topical antifungal agents is being increasingly encountered, the sensitivity pattern of dermatophytes has not been systematically analysed.
We aimed to determine the sensitivity pattern of dermatophyte isolates to amphotericin B and six oral antifungal drugs.
Patients with dermatophytosis attending the outpatient department of dermatology were enrolled in the study. Samples were collected for mycological examination and in vitro antifungal sensitivity testing was done by broth microdilution as per the Clinical and Laboratory Standard Institute M38-A standards.
A total of 804 patients were enrolled. Specimens from 185 patients (23%) were both KOH and culture positive, and 44 of these isolates (41 Trichophyton mentagrophytes and 3 Trichophyton rubrum) were subjected to sensitivity testing. Minimum inhibitory concentrations (MIC) of itraconazole, ketoconazole, voriconazole and amphotericin B were comparable. The median MIC to fluconazole was higher than the other tested drugs. Dermatophytes were most susceptible to ketoconazole and voriconazole, followed by itraconazole, amphotericin B, fluconazole and griseofulvin. A high incidence of resistance was found to terbinafine and the difference was statistically significant in comparison to fluconazole, itraconazole, voriconazole, ketoconazole (P = 0.001) and griseofulvin (P = 0.003). The strains were more sensitive to amphotericin B as compared to griseofulvin (P = 0.02) and terbinafine (P < 0.001).
This was a hospital-based study and may not reflect the true pattern in the community. Only a few of the isolates were selected for study. The clinical response of patients, whose isolates were studied for in vitro sensitivity of the antifungals, was not studied.
The sensitivity pattern of dermatophytes to various antifungals including amphotericin B, ketoconazole, voriconazole and itraconazole were determined. The studied isolates were least susceptible to terbinafine.
皮肤癣菌病是我国的一个主要公共卫生问题。尽管越来越多地遇到对抗真菌药物的常规口服和局部治疗的耐药性,但尚未对皮肤癣菌的敏感性模式进行系统分析。
我们旨在确定皮肤癣菌分离株对两性霉素 B 和六种口服抗真菌药物的敏感性模式。
本研究纳入了皮肤科门诊就诊的皮肤癣菌病患者。采集样本进行真菌学检查,并按照临床和实验室标准协会 M38-A 标准进行肉汤微量稀释法进行体外抗真菌药敏试验。
共纳入 804 例患者。185 例(23%)患者的 KOH 和培养均为阳性,其中 44 例分离株(41 株为须癣毛癣菌和 3 株红色毛癣菌)进行了药敏试验。伊曲康唑、酮康唑、伏立康唑和两性霉素 B 的最小抑菌浓度(MIC)相当。氟康唑的 MIC 中位数高于其他测试药物。皮肤癣菌对酮康唑和伏立康唑最敏感,其次是伊曲康唑、两性霉素 B、氟康唑和灰黄霉素。特比萘芬的耐药率较高,与氟康唑、伊曲康唑、伏立康唑、酮康唑(P=0.001)和灰黄霉素(P=0.003)相比差异有统计学意义。与灰黄霉素(P=0.02)和特比萘芬(P<0.001)相比,该菌株对两性霉素 B 的敏感性更高。
这是一项基于医院的研究,可能无法反映社区中的真实情况。仅选择了少数分离株进行研究。未研究对所选分离株进行体外抗真菌药敏试验的患者的临床反应。
确定了皮肤癣菌对各种抗真菌药物(包括两性霉素 B、酮康唑、伏立康唑和伊曲康唑)的敏感性模式。研究分离株对特比萘芬的敏感性最低。